Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM
ClinicalTrials.gov study NCT06045286. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT
ClinicalTrials.gov study NCT06622031. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubi
ClinicalTrials.gov study NCT04843267. IPD Sharing: NO. Countries: 1. Publications: 0.
SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome
ClinicalTrials.gov study NCT06774534. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions
ClinicalTrials.gov study NCT02041273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
ClinicalTrials.gov study NCT06888037. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05042375. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
IBI310 in Combination With Siltilimab in Subjects With Anti-PD-1/PD-L1 Resistance R/M NPC
ClinicalTrials.gov study NCT04945421. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Bilateral GPI DBS on Freezing of Gait in PD
ClinicalTrials.gov study NCT03227250. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
ClinicalTrials.gov study NCT06542250. IPD Sharing: YES. Countries: 10. Publications: 0.
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers
ClinicalTrials.gov study NCT01821066. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection
ClinicalTrials.gov study NCT03914352. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
ClinicalTrials.gov study NCT02842125. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R
ClinicalTrials.gov study NCT04022317. IPD Sharing: NO. Countries: 1. Publications: 0.
Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers
ClinicalTrials.gov study NCT03931668. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC
ClinicalTrials.gov study NCT05669846. IPD Sharing: NO. Countries: 1. Publications: 0.
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies
ClinicalTrials.gov study NCT05803928. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
ClinicalTrials.gov study NCT06205628. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Exosomes Implication in PD1-PD-L1 Activation in OSAS
ClinicalTrials.gov study NCT03811600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
ClinicalTrials.gov study NCT06222944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.